Article metrics

Download PDFPDF

Extended report
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

 

Online download statistics by month:

Online download statistics by month: January 2018 to January 2024

AbstractFullPdf
Jan 201817241776477
Feb 2018782779273
Mar 2018637631202
Apr 2018281282115
May 2018956958108
Jun 201831131457
Jul 201822922869
Aug 201817717759
Sep 201817017049
Oct 201890490464
Nov 201865765797
Dec 201816416446
Jan 201919319067
Feb 201918718597
Mar 2019216211107
Apr 201924624494
May 201922221562
Jun 201924423080
Jul 201921020667
Aug 201920019463
Sep 201944844468
Oct 201921620973
Nov 2019184181115
Dec 201920520282
Jan 202019819384
Feb 2020149131109
Mar 2020226213109
Apr 2020217200129
May 202019316771
Jun 2020229215121
Jul 2020187177113
Aug 202017316161
Sep 2020226197123
Oct 2020202193111
Nov 2020246223108
Dec 202020318975
Jan 2021183160126
Feb 202114313591
Mar 2021185165101
Apr 202114913871
May 202114513380
Jun 202115414296
Jul 2021184171101
Aug 202120719078
Sep 202116214789
Oct 202112310580
Nov 2021198172107
Dec 202113212274
Jan 202215114186
Feb 202215013964
Mar 202224923094
Apr 202221019871
May 202221319788
Jun 2022180182120
Jul 202217216671
Aug 202217315859
Sep 202219919161
Oct 2022209198100
Nov 202217716676
Dec 202214513359
Jan 202322420389
Feb 202327426786
Mar 2023233209101
Apr 202317015783
May 20231851764909
Jun 202377276058
Jul 202324623974
Aug 20231349134075
Sep 202369768770
Oct 202380579983
Nov 202329292906195
Dec 202344542090
Jan 202410261025140
Total257602507711901